Business Context and Reporting Period
This Form 8-K Current Report was filed by Natural Grocers by Vitamin Cottage, Inc. on March 8, 2019, regarding events occurring on March 6, 2019. The report details the outcomes of the Company's 2019 Annual Meeting of Stockholders held in Lakewood, Colorado.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Corporate Actions
The filing reports the following material actions approved by stockholders at the Annual Meeting:
- Director Elections: Stockholders elected Elizabeth Isely and Richard Hallé as Class I directors for three-year terms expiring in 2022.
- Accounting Firm Ratification: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2019.
- Compensation Plan Amendment: Stockholders approved amendments to the 2012 Omnibus Incentive Plan to increase the number of shares reserved for issuance by 600,000 and extend the plan's term by five years.
Voting Results and Management Commentary
A total of 20,711,772 shares were represented at the meeting, constituting approximately 92.4% of outstanding shares entitled to vote. The voting results were as follows:
| Proposal | For | Against | Abstain/Withheld | Broker Non-Votes |
|---|---|---|---|---|
| Election of Elizabeth Isely | 15,512,158 | - | 3,283,262 (Withheld) | 1,916,352 |
| Election of Richard Hallé | 18,417,390 | - | 378,030 (Withheld) | 1,916,352 |
| Ratification of KPMG LLP | 20,314,302 | 378,295 | 19,175 | 0 |
| Amendment to 2012 Plan | 18,339,847 | 450,506 | 4,164 | 1,917,255 |
Management commentary is limited to the confirmation that all three proposals were approved. No specific risks, contingencies, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify the terms of the amended 2012 Omnibus Incentive Plan (Exhibit 10.49) to understand the impact of the 600,000 share increase and term extension on future dilution.
- Review the Company's proxy statement filed on January 18, 2019, for detailed biographies of the newly elected directors and the rationale for the plan amendments.
- Confirm the Company's upcoming fiscal year-end financial reporting schedule, as KPMG was ratified for the fiscal year ending September 30, 2019.